Cognitive Impairment After Stroke: Neuroimaging Biomarkers, Artificial Intelligence, and Precision Medicine Approaches

Post-stroke cognitive impairment (PSCI) is a common and disabling consequence of stroke, arising from the complex interplay of vascular injury, cerebral small vessel disease, network disruption, neuroinflammation, neurodegeneration, and individual susceptibility factors. Advances in neuroimaging have improved understanding of PSCI pathophysiology and enabled the identification of imaging biomarkers associated with cognitive outcomes. This narrative review provides a comprehensive overview of current neuroimaging markers relevant to PSCI, including conventional magnetic resonance imaging, diffusion tensor imaging, resting-state functional MRI, arterial spin labeling, positron emission tomography, and connectome-based approaches. Particular attention is devoted to radiomics and artificial intelligence (AI), including machine learning, deep learning, explainable AI, multimodal AI, and foundation models, which are increasingly investigated approaches for biomarker discovery, biological phenotyping, and prediction of cognitive outcomes. The review further examines multimodal frameworks that integrate neuroimaging, radiomic features, blood-based biomarkers, digital biomarkers, and AI-driven analytics to support risk assessment and prognostic stratification. Despite considerable progress, important challenges remain, including methodological heterogeneity, limited standardization, insufficient external validation, concerns regarding model interpretability, and regulatory barriers to clinical implementation. Emerging technologies, such as federated learning, foundation models, digital twins, and large language models, may further contribute to the advancement of precision neurology. The convergence of multimodal biomarkers, advanced analytical approaches, and digital-health technologies may improve prognostic assessment, support individualized management strategies, and facilitate the translation of precision-medicine approaches into routine clinical care for individuals with PSCI.

Authors

Institutions

Publication Details

Journal
Applied Sciences
Published
2026-11-16
DOI
https://doi.org/10.3390/app162211345
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cognitive Impairment After Stroke: Neuroimaging Biomarkers, Artificial Intelligence, and Precision Medicine Approaches

Mauro Silvestrini, Andrea Giovagnoni, Gabriele Polonara, Chiara Bugari et al.
3 links
Applied Sciences
Dementia and Cognitive Impairment Research
article

Cognitive Impairment After Stroke: Neuroimaging Biomarkers, Artificial Intelligence, and Precision Medicine Approaches

Mauro Silvestrini, Andrea Giovagnoni, Gabriele Polonara, Chiara Bugari, Azzurra Biagiotti, Camilla Amadio
article en

Abstract

Post-stroke cognitive impairment (PSCI) is a common and disabling consequence of stroke, arising from the complex interplay of vascular injury, cerebral small vessel disease, network disruption, neuroinflammation, neurodegeneration, and individual susceptibility factors. Advances in neuroimaging have improved understanding of PSCI pathophysiology and enabled the identification of imaging biomarkers associated with cognitive outcomes. This narrative review provides a comprehensive overview of current neuroimaging markers relevant to PSCI, including conventional magnetic resonance imaging, diffusion tensor imaging, resting-state functional MRI, arterial spin labeling, positron emission tomography, and connectome-based approaches. Particular attention is devoted to radiomics and artificial intelligence (AI), including machine learning, deep learning, explainable AI, multimodal AI, and foundation models, which are increasingly investigated approaches for biomarker discovery, biological phenotyping, and prediction of cognitive outcomes. The review further examines multimodal frameworks that integrate neuroimaging, radiomic features, blood-based biomarkers, digital biomarkers, and AI-driven analytics to support risk assessment and prognostic stratification. Despite considerable progress, important challenges remain, including methodological heterogeneity, limited standardization, insufficient external validation, concerns regarding model interpretability, and regulatory barriers to clinical implementation. Emerging technologies, such as federated learning, foundation models, digital twins, and large language models, may further contribute to the advancement of precision neurology. The convergence of multimodal biomarkers, advanced analytical approaches, and digital-health technologies may improve prognostic assessment, support individualized management strategies, and facilitate the translation of precision-medicine approaches into routine clinical care for individuals with PSCI.

Applied SciencesVol. 16(22)
Marche Polytechnic University (IT)
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon